NAM
PBLA

NewGen Asset Management’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

NewGen Asset Management’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2
Closed -$113K – 56
2021
Q2 		$113K Buy
+2
New +$195K 0.04% 45

Other funds holding PBLA

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BSW
Buckingham Strategic Wealth Clayton, Missouri $9.66B AUM 15.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NewGen Asset Management's PBLA Position: Q3 2021 in Review

NewGen Asset Management sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q3 2021, closing a stake of 2 shares — an estimated $113K sold.

NewGen Asset Management first reported a position in PBLA in Q2 2021 and held it in 1 quarter. The position peaked at $113K in Q2 2021. 12 funds tracked by Wall St. Rank hold PBLA as of Q3 2021.

  • NewGen Asset Management reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • NewGen Asset Management sold 2 Panbela Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $113K.
  • NewGen Asset Management first reported a position in Panbela Therapeutics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • NewGen Asset Management's Panbela Therapeutics, Inc. Common Stock position peaked at $113K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q3 2021.

Based on NewGen Asset Management's 13F filing for Q3 2021, filed 2 Nov 2021.